Although Bristol-Myers changed the label on its Kenalog steroid seven months ago to say that it’s “not recommended” for injection into the epidural space near the spine, the steroid is still being ...
The U.S. Food and Drug Administration is reviewing epidural injections of steroids to treat neck and back pain following a warning by Bristol-Myers Squibb (NYSE:BMY) seven months ago that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results